These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 4189145)

  • 1. [Antinuclear factors. Clinical and humoral correlations; diagnostic importance].
    Purice S; Gheorghiu M; Ghelerter L; Drăgoi T
    Med Interna (Bucur); 1969 Oct; 21(10):1205-40. PubMed ID: 4189145
    [No Abstract]   [Full Text] [Related]  

  • 2. [The fall of blood complement level in pathology. Study of 50 cases].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jul; 1(28):1883-8. PubMed ID: 4115492
    [No Abstract]   [Full Text] [Related]  

  • 3. [Determination of antinuclear antibodies, anti-DNA antibodies, C 3 complement factor and IgG in lupus erythematosus and rheumatoid arthritis].
    Lehmann C; Hurtado R; Valdivieso M; Godoy G; Sorensen R
    Rev Med Chil; 1972; 100(5):485-9. PubMed ID: 4114175
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antinuclear antibodies and beta1A concentration in systemic lupus erythematosus and other diseases].
    Monegat JN; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1974 Nov; 104(45):1614-23. PubMed ID: 4612703
    [No Abstract]   [Full Text] [Related]  

  • 5. Antinuclear antibodies and complement in rheumatic diseases.
    Maini RN
    Rep Rheum Dis; 1977 Jan; (60):1-4. PubMed ID: 64996
    [No Abstract]   [Full Text] [Related]  

  • 6. Rheumatoid arthritis and systemic lupus erythematosus (SLE).
    Beer TC; Gumpel JM
    Proc R Soc Med; 1973 Sep; 66(9):910. PubMed ID: 4141773
    [No Abstract]   [Full Text] [Related]  

  • 7. [Our experience in the study of nuclear and antinuclear constituant antibodies in rheumatology].
    Kahn MF; Dryll A; de Seze S
    J Belge Rhumatol Med Phys; 1967; 22(4):217-30. PubMed ID: 4185873
    [No Abstract]   [Full Text] [Related]  

  • 8. [Connective tissue diseases with immune disorders (collagen diseases)].
    Strukov AI; Simakova RA; Kop'eva TN; Kakturskiĭ LV
    Arkh Patol; 1970; 32(7):20-35. PubMed ID: 4100744
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical significance of antinuclear antibodies with hypocomplementemia.
    Morris JL; Zizic TM; Shulman LE; Stevens MB
    Johns Hopkins Med J; 1973 Dec; 133(6):321-8. PubMed ID: 4543273
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical importance of complement research in rheumatic diseases].
    Tanner E; Wessel G
    Z Gesamte Inn Med; 1980 Dec; 35(24):191-2 contd. PubMed ID: 6971535
    [No Abstract]   [Full Text] [Related]  

  • 11. [Autoallergic diseases. II].
    Feo F
    Minerva Med; 1978 Oct; 69(51):3546-9. PubMed ID: 83553
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum complement and synovial complement. Respective variations in rheumatic pathology].
    Kourilsky O; Peltier AP; de Sèze S
    Nouv Presse Med; 1972 Jun; 1(26):1769-76. PubMed ID: 4538278
    [No Abstract]   [Full Text] [Related]  

  • 13. [Rheumatology in 1971-72-73-74].
    Auquier L; Peltier A; Paolaggi JB
    Rev Prat; 1975 Jun; 25(35):2717-51. PubMed ID: 170659
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complement activity in the serum and synovial fluid of various rheumatoid diseases].
    Richter H; Thumb N; Gangl A; Zilcher H; Hornich R
    Verh Dtsch Ges Rheumatol; 1972; 2():Suppl 2:106-10. PubMed ID: 4538173
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antinuclear factors. I. Clinical and immuno-pathologic significance].
    Peltier AP
    Presse Med (1893); 1970 Oct; 78(45):1969-73. PubMed ID: 4098224
    [No Abstract]   [Full Text] [Related]  

  • 16. [Titers of C 3 factor of serum complement in various autoimmune diseases].
    Lehman C; Andreis M; Bennett L; Godoy G
    Rev Med Chil; 1972; 100(5):497-501. PubMed ID: 4625016
    [No Abstract]   [Full Text] [Related]  

  • 17. The immunofluorescent "band" test for lupus erythematosus. 3. Employing clinically normal skin.
    Burnham TK; Fine G
    Arch Dermatol; 1971 Jan; 103(1):24-32. PubMed ID: 4099590
    [No Abstract]   [Full Text] [Related]  

  • 18. Quantitative studies of immunofluorescent staining. VI. Defined complement immunofluorescent staining for antinuclear antibodies in systemic lupus and other collagen diseases.
    Diaz Gill GA; Beutner EH; Eisenberg RB
    Int Arch Allergy Appl Immunol; 1973; 45(6):868-79. PubMed ID: 4586867
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of reduced complement level in the articular fluid. 81 cases].
    Del Pino Montes J; Meyer O; Borda Iriarte O; Belenguer Prieto R; Peltier AP; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Jan; 50(1):19-21. PubMed ID: 6601817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Contribution of immunology to rheumatology].
    Serre H
    Lille Med; 1977; 22(6):391-8. PubMed ID: 302379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.